The Relative Effects of Olmesartan Medoxomil, Irbesartan and Valsartan on the Activity of the Blood Pressure Control System in Healthy Subjects

• Status: Completed
• Trial end date: 2005-02-01
• Target enrollment: 0
• Participant gender: All

Summary

To assess the effects of 3 blood pressure drugs, called angiotensin receptor blockers, on the blood pressure control systems in healthy subjects.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Daiichi Sankyo Inc.; Daiichi Sankyo, Inc.
• Treatments: Irbesartan; Olmesartan; Olmesartan Medoxomil; Valsartan

Criteria

Inclusion Criteria:

• Men and women between the ages of 18 to 65

• In good health

Exclusion Criteria:

• Any serious health problems

• Positive test for HIV, Hepatitis B and C

• History of drug and alcohol abuse